Global Investing Roundups

Eli Outbids Bristol; Carmax Crashes; IBM Could Miss Estimates; Micron's Loss; Cereal's Sugar High; Canada Drives Toyota

  • Eli Lilly and Co. (LLY) is in advanced talks to acquire ImClone Systems Inc (IMCL) for $70 a share, topping a rival bid from Bristol-Myers Squibb Co. (BMY), the Wall Street Journal reported yesterday (Wednesday). Bristol already owns about 17% of ImClone and has submitted an unsolicited $62-a-share bid of its own for the biotech company.

  • CarMax Inc. (KMX) said yesterday (Wednesday) that it will layoff more than 600 employees, or 4% of its total work force, as it struggles with harsh credit conditions and low sales, The Associated Press reported. CarMax shares fell 64 cents, or 4.6%, to close at $13.36.

  • Auto sales in Canada increased 1.7% in September, Bloomberg News reported. Toyota Motor Corp. (ADR: TM) had a 14% increase, which helped offset declines from both General Motors Corp. (GM) and Ford Motor Co. (F). Car sales climbed 5.1% while light truck sales slipped 2.2%.